SCHEMBL3387701

SCHEMBL3387701

Cc1ccc(NC(=O)Nc2ccc(N3CCN(C)CC3)c(C(F)(F)F)c2)cc1-c1ccc2c(C(=O)O)n[nH]c2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 7/20 0.51
DDR2 Q16832 6/20 0.51
CSF1R P07333 2/20 0.45
PDGFRA P16234 2/20 0.45
FLT4 P35916 2/20 0.45
FLT3 P36888 1/20 0.45
KCNH2 Q12809 1/20 0.45
KDR P35968 7/20 0.45
KIT P10721 2/20 0.45
PRKAB2 O43741 1/20 0.44
PRKAG1 P54619 1/20 0.44
PRKAA2 P54646 1/20 0.44
PRKAA1 Q13131 1/20 0.44
PRKAG3 Q9UGI9 1/20 0.44
PRKAG2 Q9UGJ0 1/20 0.44
PRKAB1 Q9Y478 1/20 0.44
ABL1 P00519 1/20 0.42
BCR P11274 1/20 0.42
FGFR2 P21802 1/20 0.42
BRAF P15056 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3382995 0.90 FGFR1 (0.48) FGFR1DDR2CSF1RPDGFRAFLT4
SCHEMBL3384269 0.89 CSF1R (0.48) FGFR1DDR2CSF1RPDGFRAFLT4
SCHEMBL3385938 0.83 KDR (0.54) KDRBRAF
SCHEMBL3386643 0.81 CSF1R (0.47) FGFR1DDR2CSF1RPDGFRAFLT4
SCHEMBL8739803 0.76 KDR (0.49) FGFR1DDR2CSF1RFLT4FLT3
SCHEMBL3384548 0.74 KDR (0.49) KDRABL1BCRBRAF
SCHEMBL3387502 0.74 RAF1 (0.55) KITABL1BCRBRAF
SCHEMBL3386109 0.74 KDR (0.50) KDRBRAF
SCHEMBL3387495 0.73 RAF1 (0.53) FGFR1DDR2KDRBRAF
SCHEMBL25241289 0.73 NPY2R (0.54) CSF1RPDGFRAFLT4FLT3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010064875-A2 NOVEL INDAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS PROTEIN KINASE INHIBITORS FOR PROLIFERATIVE DISEASES TREATMENT, AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS AN ACTIVE INGREDIENT KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2010-06-10 WO claimed
WO-2010064875-A2 NOVEL INDAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS PROTEIN KINASE INHIBITORS FOR PROLIFERATIVE DISEASES TREATMENT, AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS AN ACTIVE INGREDIENT KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2010-06-10 WO disclosed